Your browser doesn't support javascript.
loading
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome.
Buso, Giacomo; Faggin, Elisabetta; Bressan, Alessandro; Galliazzo, Silvia; Cinetto, Francesco; Felice, Carla; Fusaro, Michele; Erdmann, Andreas; Pauletto, Paolo; Rattazzi, Marcello; Mazzolai, Lucia.
Afiliación
  • Buso G; Angiology Division, Heart and Vessel Department, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
  • Faggin E; Department of Clinical and Experimental Sciences, 2a Medicina-Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia, University of Brescia, 25100 Brescia, Italy.
  • Bressan A; Department of Medicine-DIMED, University of Padua, 35122 Padua, Italy.
  • Galliazzo S; Department of Medicine-DIMED, University of Padua, 35122 Padua, Italy.
  • Cinetto F; Department of Internal Medicine Unit, Ospedale S. Valentino, 31044 Montebelluna, Italy.
  • Felice C; Department of Medicine-DIMED, University of Padua, 35122 Padua, Italy.
  • Fusaro M; Medicina Interna I, Ca' Foncello University Hospital, 31100 Treviso, Italy.
  • Erdmann A; Department of Medicine-DIMED, University of Padua, 35122 Padua, Italy.
  • Pauletto P; Medicina Interna I, Ca' Foncello University Hospital, 31100 Treviso, Italy.
  • Rattazzi M; Department of Radiology, Ca' Foncello University Hospital, 31100 Treviso, Italy.
  • Mazzolai L; Angiology Division, Heart and Vessel Department, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
Biomedicines ; 11(3)2023 Mar 12.
Article en En | MEDLINE | ID: mdl-36979845
ABSTRACT
Neutrophils play a role in cardiovascular (CV) disease. However, relatively scant evidence exists in the setting of peripheral artery disease (PAD). The aims of this study were to measure biomarkers of neutrophil activation in patients with symptomatic chronic PAD compared with healthy controls, to assess their association with PAD severity, and to evaluate their prognostic value in patients with PAD. The following circulating markers of neutrophil degranulation were tested polymorphonuclear neutrophil (PMN) elastase, neutrophil gelatinase-associated lipocalin (NGAL), and myeloperoxidase (MPO). Neutrophil extracellular traps (NETs) were quantified by measuring circulating MPO-DNA complexes. Patients with PAD underwent a comprehensive series of vascular tests. The occurrence of 6-month major adverse CV (MACE) and limb events (MALE) was assessed. Overall, 110 participants were included, 66 of which had PAD. After adjustment for conventional CV risk factors, PMN-elastase (adjusted odds ratio [OR] 1.008; 95% confidence interval [CI] 1.002-1.015; p = 0.006), NGAL (adjusted OR 1.045; 95%CI 1.024-1.066; p < 0.001), and MPO (adjusted OR 1.013; 95%CI 1.001-1.024; p = 0.028) were significantly associated with PAD presence. PMN-elastase (adjusted hazard ratio [HR] 1.010; 95%CI 1.000-1.020; p = 0.040) and MPO (adjusted HR 1.027; 95%CI 1.004-1.051; p = 0.019) were predictive of 6-month MACE and/or MALE. MPO displayed fair prognostic performance on receiver operating characteristic (ROC) curve analyses, with an area under the curve (AUC) of 0.74 (95%CI 0.56-0.91) and a sensitivity and specificity of 0.80 and 0.65, respectively, for a cut-off of 108.37 ng/mL. MPO-DNA showed a weak inverse correlation with transcutaneous oximetry (TcPO2) on proximal foot (adjusted ρ -0.287; p = 0.032). In conclusion, in patients with symptomatic chronic PAD, enhanced neutrophil activity may be associated with an increased risk of acute CV events, rather than correlate with disease severity. Further research is needed to clarify the role of neutrophils in PAD natural history.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Suiza